5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia

2006 ◽  
Vol 120 (4) ◽  
pp. 776-780 ◽  
Author(s):  
Vanessa M. Hayes ◽  
Gianluca Severi ◽  
Emma J.D. Padilla ◽  
Howard A. Morris ◽  
Wayne D. Tilley ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Prostate Cancer Risk ◽  
Androgenetic Alopecia ◽  
Gene Variant ◽  
Hormone Levels

scholarly journals No Association of Type 2 Diabetes Risk Variants and Prostate Cancer Risk: the Multiethnic Cohort and PAGE: Table 1.

2011 ◽  
Vol 20 (9) ◽  
pp. 1979-1981 ◽  
Author(s):  
Kevin M. Waters ◽  
Lynne R. Wilkens ◽  
Kristine R. Monroe ◽  
Daniel O. Stram ◽  
Laurence N. Kolonel ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Type 2 Diabetes ◽  
Cancer Risk ◽  
Prostate Cancer Risk ◽  
Diabetes Risk ◽  
Risk Variants ◽  
Multiethnic Cohort ◽  
Page Table

scholarly journals Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case–control series of veterans

2013 ◽  
Vol 24 (5) ◽  
pp. 1045-1052 ◽  
Author(s):  
Jean-Alfred Thomas ◽  
Jodi A. Antonelli ◽  
Lionel L. Banez ◽  
Catherine Hoyo ◽  
Delores Grant ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Prostate Cancer Risk ◽  
Case Control ◽  
Equal Access ◽  
Androgenetic Alopecia ◽  
Control Series

scholarly journals Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: implication for prostate cancer risk

2004 ◽  
Vol 7 (4) ◽  
pp. 333-337 ◽  
Author(s):  
H Kakinuma ◽  
N Tsuchiya ◽  
T Habuchi ◽  
C Ohyama ◽  
S Matsuura ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Cancer Risk ◽  
Steroid Hormone ◽  
Prostate Cancer Risk ◽  
Sex Steroid ◽  
Sex Steroid Hormone ◽  
Hormone Levels
Sign in / Sign up

Export Citation Format

Share Document